Corel Medical Series: Cancer/Corel Medical Series: Cancer.iso/mac/Program/Indexdat/indexc.D

Text File | 1997-01-27 | 4KB | 2 lines

Dacarbazine,13,Dactinomycin,P11.5;C10B.18;C36.11,Daunomycin,C16.16,Death,2,2-Deoxycoformycin,C18.23;C18.28,Desire,P23.3,Detoxification,P13.10;P13.11,Dexamethasone,5,Dexrazoxane,P35.16,Diabetes risk factor,C44.3;C45.4,Diagnosis,11,Diarrhea,3,Diazoxide,C15.13;C15.15,Dienestrol,P23.21,Diet,13,Dietary therapies,P13.11,Diethylstilbestrol (DES),C35.29;C40.4;C46.2,Diffuse intermediate lymphocytic lymphoma,C24.15,Difluorodeoxycytidine,P35.9,Digital rectal examination,P34.18,Dilatation and curettage (D&C),C43.13,Diphenhydramine,chr.p17.14;p17.18;c03.17,Dipyridamole,P35.16;C31.11,Direct spread,P01.10,Disbelief,P29.5,Discharge planning,P26.3,Discovery,P29.6,Discrimination,P31.7,Diuretics,P17.23,DNA,P01.1;P01.6;P04.4;P36.1;P36.2;P36.3;P36.4,Doctor,5,Docusate calcium,p17.24,Docusate sodium,P17.24,Donnatal,p17.30;P18.20,Dosimetrist,P06.5,Doubling times cancerous growth,1,Down's syndrome,C10A.5,Doxidan,P17.24,Doxorubicin,28,Droperidol,chr.p17.14 ,Drug patches,P19.13,Drugs,20,Dry mouth,P18.15,Ductal carcinoma,2,Duodenum diagram,C13.8,Durable Power of Attorney,P32.6,Dydroxyzine,c03.17,Dysgerminoma,C30.1,
for adrenal gland cancer,C01.16,for bone and soft tissue sarcomas,C36.11;C36.12;C36.18,for gastrointestinal cancer,C08.14,for Hodgkin's disease,C23.15,for islet cell carcinoma,C15.10,for mesothelioma,c26.16,for parathyroid cancer,C32.11,for small intestine cancer,C38.12,for stomach cancer,C39.24,for uterine cancer,C45.10;C45.12;C45.14,for vaginal cancer,C46.13,in hyperthermic perfusion,P11.5,side effects,chr.p17.13,coping with,P27.2;P27.3;P27.4;P27.7;P27.9;P27.10;P29.1,preparing for,P27.10;P32.3;P32.5,for brain tumor,c05.22;c27.7,for leukemia,c18.17,for lymphoma,C24.19;C24.20;,for multiple myeloma,C28.21,to control nausea,chr.p17.14,biopsy,P02.22;P05.4,blood tests,P02.6;P02.7,bone marrow analysis,P02.21,cytological studies,P02.19,endoscopy,P02.17,fluid tests,P02.9,genetic,P36.9,imaging techniques,P02.17,physical examination,P02.5,stool tests,P02.9,symptoms,P02.3,causes,P06.19;P17.27;P17.28;P20.5,home care,P26.9,treatment,P17.28,best approach,P18.8;C11C.18,calorie table,chr.p18.7,constipation,P17.25,diarrhea,P17.28;P17.29,improving,P34.11,loss of appetite,P17.20,nausea,P17.11,ostomy,p21.12,problems,P18.3,radiation therapy,P18.14;P18.15;P18.16;P18.17;P18.18;P18.19;P18.20,risk factor,P34.6;C11A.4;C12.4;C39.5;C42.4,sore mouth,P17.19,supplements,P18.8;P18.11;P18.12,communicating with,P03.13;P03.14;P30.6,responsibility,p03.13,role,P03.3;P03.4;P03.5,teamed with nurse,P15.6,understanding,P03.10,video,P01.3,for anal cancer,c02.17,for bladder cancer,C04.18;C04.24,for bone and soft tissue sarcomas,C36.11;C36.12;C36.13;C36.18,for breast cancer,C06.42;C06.53,for esophageal cancer,c12.20,for gastrointestinal cancer,C08.14,for head and neck cancer,C14B.17;C14B.19,for Hodgkin's disease,C23.20,for islet cell carcinoma,C15.12,for Kaposi's sarcoma,c16.16,for leukemia,C18.19,for liver cancer,c19.14;c19.16,for lung cancer,c21.13,for lymphoma,c22.7;c22.8,for mesothelioma,C26.11;C26.12;C26.16,for multiple myeloma,C28.13,for osteogenic sarcoma,C10D.8,for ovarian cancer,c29.23,for pancreatic cancer,c31.11,for prostate cancer,C35.32,for small intestine cancer,C38.12,for stomach cancer,c39.15;c39.23,for thymus cancer,C41.10,for thyroid cancer,c42.26,for uterine cancer,c44.13;c44.16;c44.17;c44.19;c44.20;c44.21,for vaginal cancer,c46.13,investigational,P35.10,side effects,chr.p17.14,alkaloids,P07.6,alkylating agents,P07.6,antimetabolites,P07.6,antinausea,chr.p17.14,antitumor antibiotics,P07.6,approved uses,P35.6,causing nausea (table),chr.p17.13,clinical trials,P04.17;P07.2;P35.1;P35.2,colony-stimulating factors,P07.23,combinations,P07.3;P07.7;P35.5,hormones,P07.6,investigational,P35.1,myths,P19.11,non-cell-cycle-specific,P07.7,promoting cancer,P01.8,resistance to,P07.7,selection,P07.16,sensitivity,P07.17,sexuality,P23.8,treatment options,P19.10,breast,C06.3,prostate,C35.32,